{"id":2613,"date":"2017-02-16T03:00:26","date_gmt":"2017-02-16T08:00:26","guid":{"rendered":"https:\/\/issels.com\/blog\/?p=2613"},"modified":"2017-01-19T10:44:20","modified_gmt":"2017-01-19T15:44:20","slug":"new-medication-may-effectively-treat-triple-negative-breast-cancer","status":"publish","type":"post","link":"https:\/\/issels.com\/blog\/2017\/02\/16\/new-medication-may-effectively-treat-triple-negative-breast-cancer\/","title":{"rendered":"New Medication May Effectively Treat Triple-Negative Breast Cancer"},"content":{"rendered":"
\"Cancer
Breast Cancer Research<\/figcaption><\/figure>\n

The term <\/span>“breast cancer”<\/span><\/a> encompasses several subtypes of the diseases, including <\/span>triple-negative breast cancer<\/span><\/a>, a more aggressive form that occurs frequently in younger women. Scientists in Ireland recently made a discovery that holds promise as an more effective treatment than chemotherapy, which is currently the only available option for this cancer subtype.<\/span><\/p>\n

What Is Triple-Negative Breast Cancer?<\/span><\/strong><\/p>\n

Breast cancer is usually categorized by the presence or absence of three different receptors that fuel the growth of tumors. Triple-negative breast cancer lacks all three receptors, making it unresponsive to the <\/span>targeted treatments<\/span><\/a> often used with breast cancer.<\/span><\/p>\n

BREAST-PREDICT is the Irish Cancer Society Collaborative Cancer Research Centre where the recent study was conducted. Researchers identified a drug called APR-246 that can prevent the growth of certain cancer cells.<\/span><\/p>\n

APR-246 Can Mean New Hope for Breast Cancer Patients<\/span><\/strong><\/p>\n

Results of the study were published last year in the International Journal of Cancer<\/em>. Naoise Synnott, the PhD student who performed the research, said she decided to focus her efforts on triple-negative breast cancer because of the lack of effective treatment for the disease. <\/span><\/p>\n

Currently, chemotherapy is the only form of treatment available to patients with triple-negative breast cancer. Unfortunately, many of them don’t respond, leaving them to suffer the <\/span>side effects of chemotherapy<\/span><\/a> with no positive outcome.<\/span><\/p>\n

Approximately one in six cases of breast cancer worldwide is diagnosed as triple-negative. The next step with APR-246 is conducting clinical trials to evaluate real-life results.<\/span><\/p>\n

Is Immunotherapy for Cancer Right for You?<\/span><\/strong><\/p>\n

For decades, Issels\u00ae has been in the forefront of cutting-edge <\/span>immunotherapy for cancer<\/span><\/a> treatments. <\/span>Contact us<\/span><\/a> for testimonials from patients we have successfully treated for breast cancer, leukemia and other forms.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

The term “breast cancer” encompasses several subtypes of the diseases, including triple-negative breast cancer, a more aggressive form that occurs frequently in younger women. Scientists in Ireland recently made a discovery that holds promise as an more effective treatment than chemotherapy, which is currently the only available option for this cancer subtype. What Is Triple-Negative … Continue reading New Medication May Effectively Treat Triple-Negative Breast Cancer<\/span> →<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[202,473,203,538],"tags":[243,539,259],"class_list":["post-2613","post","type-post","status-publish","format-standard","hentry","category-alternative-cancer-treatment","category-breast-cancer","category-cancer-research","category-immunotherapy-for-cancer","tag-breast-cancer","tag-cancer-immunotherapy","tag-fighting-cancer"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts\/2613","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/comments?post=2613"}],"version-history":[{"count":1,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts\/2613\/revisions"}],"predecessor-version":[{"id":2614,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts\/2613\/revisions\/2614"}],"wp:attachment":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/media?parent=2613"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/categories?post=2613"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/tags?post=2613"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}